These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12071403)

  • 1. Survival analysis with time-varying regression effects using a tree-based approach.
    Xu R; Adak S
    Biometrics; 2002 Jun; 58(2):305-15. PubMed ID: 12071403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival analysis with time-varying relative risks: a tree-based approach.
    Xu R; Adak S
    Methods Inf Med; 2001 May; 40(2):141-7. PubMed ID: 11424300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A semiparametric estimate of treatment effects with censored data.
    Xu R; Harrington DP
    Biometrics; 2001 Sep; 57(3):875-85. PubMed ID: 11550940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piecewise exponential survival trees with time-dependent covariates.
    Huang X; Chen S; Soong SJ
    Biometrics; 1998 Dec; 54(4):1420-33. PubMed ID: 9883542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup study.
    Gordon LI; Andersen J; Colgan J; Glick J; Resnick GD; O'Connell M; Cassileth PA
    Cancer; 1995 Feb; 75(3):865-73. PubMed ID: 7530168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tree-based models for survival data with competing risks.
    Kretowska M
    Comput Methods Programs Biomed; 2018 Jun; 159():185-198. PubMed ID: 29650312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of regression parameters and the hazard function in transformed linear survival models.
    Gray RJ
    Biometrics; 2000 Jun; 56(2):571-6. PubMed ID: 10877318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognosis factors analysis of 56 cases of non-Hodgkin's lymphoma originating from the nasopharynx].
    Li SD; Ba YP; Zhang PW
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):651-653. PubMed ID: 31327206
    [No Abstract]   [Full Text] [Related]  

  • 9. A predictive model for aggressive non-Hodgkin's lymphoma.
    International Non-Hodgkin's Lymphoma Prognostic Factors Project
    N Engl J Med; 1993 Sep; 329(14):987-94. PubMed ID: 8141877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation, calibration, revision and combination of prognostic survival models.
    van Houwelingen HC
    Stat Med; 2000 Dec; 19(24):3401-15. PubMed ID: 11122504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized Risk Prediction in Clinical Oncology Research: Applications and Practical Issues Using Survival Trees and Random Forests.
    Hu C; Steingrimsson JA
    J Biopharm Stat; 2018; 28(2):333-349. PubMed ID: 29048993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for patients with diffuse large cell or immunoblastic non-Hodgkin's lymphomas: experience of the non-Hodgkin's Lymphoma Pathologic Classification Project.
    Simon R; Durrleman S; Hoppe RT; Bonadonna G; Bloomfield CD; Rudders RA; Cheson BD; Berard CW
    Med Pediatr Oncol; 1990; 18(2):89-96. PubMed ID: 2406556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empirical likelihood for cumulative hazard ratio estimation with covariate adjustment.
    Dong B; Matthews DE
    Biometrics; 2012 Jun; 68(2):408-18. PubMed ID: 22059527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy.
    Bower M; Gazzard B; Mandalia S; Newsom-Davis T; Thirlwell C; Dhillon T; Young AM; Powles T; Gaya A; Nelson M; Stebbing J
    Ann Intern Med; 2005 Aug; 143(4):265-73. PubMed ID: 16103470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus associated with the occurrence and prognosis of non-Hodgkin's lymphoma.
    Lin SY; Hsieh MS; Chen LS; Chiu YH; Yen AM; Chen TH
    Eur J Cancer Prev; 2007 Oct; 16(5):471-8. PubMed ID: 17923820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multivariate analysis of the survival of patients with aggressive lymphoma: variations in the predictive value of prognostic factors during the course of the disease. Groupe d'Etudes des Lymphomes de l'Adulte.
    Mounier N; Morel P; Haioun C; Coiffier B; Tilly H; Chatelain C; Lederlin P; Thyss A; Herbrecht R; Gisselbrecht C; Lepage E
    Cancer; 1998 May; 82(10):1952-62. PubMed ID: 9587130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tree-based identification of subgroups for time-varying covariate survival data.
    Bertolet M; Brooks MM; Bittner V
    Stat Methods Med Res; 2016 Feb; 25(1):488-501. PubMed ID: 23070595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary cerebral non-Hodgkin's lymphomas. The results of radiotherapy].
    Hetzel-Sesterheim M; Schnabel K; Nestle U; Hamann G; Berberich W
    Strahlenther Onkol; 1996 Apr; 172(4):198-204. PubMed ID: 8623082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
    Crocetti E; Mangone L; Lo Scocco G; Carli P
    Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.